BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.223
-0.010 (-4.21%)
At close: Apr 28, 2026, 4:00 PM EDT
0.224
+0.001 (0.27%)
After-hours: Apr 28, 2026, 6:08 PM EDT
BioRestorative Therapies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 0.36 | 0.4 | 0.15 | 0.12 | 0.05 | |
| Revenue Growth (YoY) | -10.30% | 175.03% | 21.70% | 160.44% | -40.26% | |
| Cost of Revenue | 0.02 | 0.03 | - | - | - | |
| Gross Profit | 0.34 | 0.37 | 0.15 | 0.12 | 0.05 | |
| Selling, General & Admin | 5.89 | 5.22 | 11.33 | 15.58 | 25.62 | |
| Research & Development | 10.09 | 6.71 | 4.03 | 3.51 | 0.73 | |
| Operating Expenses | 15.98 | 11.93 | 15.37 | 19.09 | 26.35 | |
| Operating Income | -15.65 | -11.56 | -15.22 | -18.97 | -26.31 | |
| Interest Expense | - | - | - | - | -1.82 | |
| Interest & Investment Income | 0.27 | 0.62 | 0.55 | 0.01 | - | |
| Other Non Operating Income (Expenses) | 1.14 | 1.96 | 4.25 | 5.49 | - | |
| EBT Excluding Unusual Items | -14.24 | -8.98 | -10.42 | -13.47 | -28.12 | |
| Other Unusual Items | - | - | - | 0.25 | -16.18 | |
| Pretax Income | -14.24 | -8.98 | -10.42 | -13.22 | -44.3 | |
| Net Income | -14.24 | -8.98 | -10.42 | -13.22 | -44.3 | |
| Net Income to Common | -14.24 | -8.98 | -10.42 | -13.22 | -44.3 | |
| Shares Outstanding (Basic) | 9 | 8 | 4 | 4 | 1 | |
| Shares Outstanding (Diluted) | 9 | 8 | 4 | 4 | 1 | |
| Shares Change (YoY) | 15.83% | 84.05% | 16.60% | 204.60% | 200.92% | |
| EPS (Basic) | -1.58 | -1.16 | -2.47 | -3.65 | -37.30 | |
| EPS (Diluted) | -1.58 | -1.16 | -2.47 | -3.65 | -37.30 | |
| Free Cash Flow | -10.91 | -8.34 | -6.6 | -6.18 | -3.36 | |
| Free Cash Flow Per Share | -1.21 | -1.07 | -1.56 | -1.71 | -2.83 | |
| Gross Margin | 93.37% | 93.00% | 100.00% | 100.00% | 100.00% | |
| Operating Margin | -4350.05% | -2881.60% | -10439.49% | -15838.08% | -57191.03% | |
| Profit Margin | -3959.40% | -2239.25% | -7145.20% | -11036.98% | -96311.51% | |
| Free Cash Flow Margin | -3031.70% | -2078.94% | -4527.61% | -5157.20% | -7305.58% | |
| EBITDA | -15.44 | -11.37 | -15.06 | -18.85 | -26.22 | |
| D&A For EBITDA | 0.21 | 0.19 | 0.17 | 0.12 | 0.09 | |
| EBIT | -15.65 | -11.56 | -15.22 | -18.97 | -26.31 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.